Monthly Update29 Aug 2025, 03:12 pm
Amrutanjan Health Care Ltd. Reports Steady Growth in FY2025, Strengthening Legacy of Relief and Building Towards a Purpose-Led Tomorrow
AI Summary
Amrutanjan Health Care Ltd. (AHCL) closed FY2025 with stable growth across its core categories, strengthening its legacy of relief while continuing to build towards a more responsive and purpose-led tomorrow. The company reported a gross sales of INR 2509.68 crore, a 2.44% increase from the previous year. The profit after tax (PAT) stood at INR 250.83 crore, a 2.43% increase. The company's net worth was INR 21,864 crore, and the market cap was INR 250.90 crore. The company distributed dividends at INR 24.60 per share. AHCL's operational highlights include 1,656 distributors, 3 state-of-the-art manufacturing units, 631 employees, 914 suppliers, and 1.11 million outlets for its rubefacient products.
Key Highlights
- AHCL reported a stable growth of 2.44% in gross sales for FY2025.
- The company's profit after tax (PAT) increased by 2.43% in FY2025.
- AHCL's net worth stood at INR 21,864 crore in FY2025.
- The company distributed dividends at INR 24.60 per share in FY2025.
- AHCL's operational highlights include 1,656 distributors, 3 state-of-the-art manufacturing units, 631 employees, 914 suppliers, and 1.11 million outlets for its rubefacient products.